In the future, new molecules, including AMPs, and new strategies, also in combination with current anti-MRSA therapies, could be used to better control the colonization of multi-resistant strains and eradicate exotoxin-producing S. aureus strains, with a potential impact on the pathogenesis of psoriasis. This evidence concerns the gene ADSL and psoriasis.